ACQUITY UPLC H-Class Bio System

Similar documents
Method Development Considerations for Reversed-Phase Protein Separations

Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus

ACQUITY UPLC. I-Class PLUS WHAT SEPARATES YOU FROM EVERYONE ELSE

ACQUITY Arc VERSATILITY WITHOUT COMPROMISE

of peptide mapping chemistries, 130Å or 300Å with tunable UV, photodiode array, or mass spectrometry

Developing Quantitative UPLC Assays with UV

Analysis of biomolecules by SEC and Ion-Exchange UPLC

Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns

2012 Waters Corporation 1

A Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies

Reducing Cycle Time for Charge Variant Analysis of Monoclonal Antibodies

Faster Separations Using Agilent Weak Cation Exchange Columns

Fast and High Resolution Analysis of Intact and Reduced Therapeutic Monoclonal Antibodies (mabs)

Proteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1

Columns for Biomolecules BioLC Column Lines

Charge Heterogeneity Analysis of Rituximab Innovator and Biosimilar mabs

Agilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis. WCBP Jan 2017 Washington, DC

H-Class & H-Class Bio AutoBlend and AutoBlend plus. Jean-Michel Plankeele May Waters Corporation 1

Technical Overview. Authors. Abstract. Verified for Agilent 1260 Infinity II LC Bio-inert System

Chromatography column for therapeutic protein analysis

Separation of Recombinant Human Erythropoietin (repo) Using Agilent Bio SEC-3

Thermo Scientific Peptide Mapping Workflows. Upgrade Your Maps. Fast, confident and more reliable peptide mapping.

High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography

and for the Development of Isolation Strategies

Optimizing Protein Separations with Agilent Weak Cation-Exchange Columns

Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

MassPREP On-Line Desalting Cartridge

Size Exclusion BioHPLC columns Ion Exchange BioHPLC columns

The Agilent 1260 Infinity BioInert Quaternary Pump. Scope of a low-pressure mixing UHPLC pump with Bio-Inert Capabilities

Altus UPLC IT S ALL ABOUT PEAK PERFORMANCE

Solutions Guide. MX Series II Modular Automation for Nano and Analytical Scale HPLC And Low Pressure Fluid Switching Applications

Separation Science Built for Biopharma

MAbPac RP Column. High-performance reverse phase chromatography column for monoclonal antibody analysis

Overview of Waters Solutions for Biopharmaceutical Analysis and Characterization

Application Note. Author. Abstract. Biotherapeutics and Biologics. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

Hichrom Limited 1 The Markham Centre, Station Road, Theale, Reading, Berkshire, RG7 4PE, UK Tel: +44 (0) Fax: +44 (0)

A highly sensitive and robust 150 µm column to enable high-throughput proteomics

ACQUITY Arc TM System

Chromatographic Workflows for Biopharmaceutical Characterization

Monoclonal Antibody Analysis on a Reversed-Phase C4 Polymer Monolith Column

Development of Ultra-fast ph-gradient Ion Exchange Chromatography for the Separation of Monoclonal Antibody Charge Variants

Thermo Scientific MAbPac HIC Columns. Novel Hydrophobic Interaction HPLC Columns. Designed for Monoclonal Antibody Analysis

Generating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI

Sean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL RESULTS AND DISCUSSION

Protein-Pak Hi Res HIC Column and HIC Protein Standard

ph gradient analysis of IgG1 therapeutic monoclonal antibodies using a 5 µm WCX column

Seamless Method Transfer from an Agilent 1260 Infinity Bio-inert LC to an Agilent 1260 Infinity II Bio-inert LC

Biochromatography Bring more Zen into your life and laboratory

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

Analysis of Intact and C-terminal Digested IgG1 on an Agilent Bio MAb 5 µm Column

Higher Order mab Aggregate Analysis using New Innovative SEC Technology

Simultaneous in vivo Quantification and Metabolite Identification of Plasma Samples Using High Resolution QTof and Routine MS E Data Analysis

Agilent 1290 Infinity 2D-LC Solution. Selectable separation performance

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

From routine to research, always the right answers.

TOYOPEARL GigaCap Series

Thermo Scientific EASY-nLC 1200 System. Leading in simplicity. and performance

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Understanding the Effects of Common Mobile Phase Additives on the Performance of Size Exclusion Chromatography

Customized systems to meet your lab s needs

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D.

BioHPLC columns. Tim Rice Biocolumn Technical Specialist

Agilent 1260 Infinity II Prime LC ACHIEVE CONVENIENCE EVERY DAY IN EVERY WAY

Rapid UHPLC Analysis of Reduced Monoclonal Antibodies using an Agilent ZORBAX Rapid Resolution High Definition (RRHD) 300SB-C8 Column

Agilent 1260 Infinity Bio-inert Quaternary LC System. Infinitely better for bio-molecule analysis

for water and beverage analysis

NISTmAb characterization with a high-performance RP chromatography column

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

The Agilent StreamSelect LC/MS Solution: Increasing the Throughput of a Triple Quadrupole Mass Spectrometer

IMPORTANCE OF CELL CULTURE MEDIA TO THE BIOPHARMACEUTICAL INDUSTRY

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

Faster, easier, flexible proteomics solutions

Purification Workflow Management

Trastuzumab Glycan Batch-to-Batch Profiling using a UPLC/FLR/Mass Spectrometry Platform

[ ACQUITY UPLC system ] Performance so strong it moved the industry forward

[ ACQUITY UPLC SYSTEM ] Performance so strong it moved the industry forward

Eoin F.J. Cosgrave, Matthew A. Lauber, Robert Birdsall, and Sean M. McCarthy Waters Corporation, Milford, MA, USA APPLICATION BENEFITS INTRODUCTION

Application Note. Authors. Abstract. Biopharmaceuticals

Using Empower SystemsQT Qualification Tool

Thermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development

SEC-MS with Volatile Buffers for Characterization of Biopharmaceuticals

E f f ic i ent ly Com pa ring Bat c h e s o f a n Intac t Mono c lo na l A n t ibo dy using t h e

Mass Spectrometry Analysis of Liquid Chromatography Fractions using Ettan LC MS System

R R Innovation Way P/N SECKIT-7830 Newark, DE 19711, USA Tel: Fax: Website: Published in November 2013

Dedicated UPLC Chemistries for BioTherapeutics Joe Walsh WITS BioPharm Session 2016

Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q TOF

Reversed-phase Separation of Intact Monoclonal Antibodies Using Agilent ZORBAX Rapid Resolution High Definition 300SB-C8 1.

Mobile Phase Optimization in SEC Method Development

Automated Method Development With UPLC and Fusion Software A Quality by Design-based Tool Jean-Michel Plankeele May Waters Corporation 1

Improved SPE for UPLC/MS Determination of Diquat and Paraquat in Environmental

Agilent Prep LC Columns for Small Molecules and Biomolecules MAINTAIN RAPID, RELIABLE SEPARATIONS AS YOU SCALE-UP

4/4/2013. BioHPLC columns. Paul Dinsmoor Biocolumn Technical Specialist. April 23-25, Size Exclusion BioHPLC Columns

columns P r o P a c H I C C o l u m n S o l u t i o n s f o r P r o t e i n A n a l y s i s

[ VION IMS QTOF ] BEYOND RESOLUTION

API 3200 LC/MS/MS system

mab and ADC Analysis Shanhua Lin, Ph.D. The world leader in serving science

Transcription:

QUITY UPL H-lass io System uilt for your biomolecular characterization t he IocoM Pt Ile u P lc P lt FoRM The QUITY UPL H-lass io System the latest extension to the family of QUITY UPL Systems, brings the benefits of UPLt Technology to the analysis of biological macromolecules. This system is designed and developed for the types of complex samples that often require multiple chromatographic techniques for the complete characterization of biomolecules. UPL Technology has already been proven to deliver improved chromatographic results with enhanced productivity to laboratories seeking robust characterization in bioseparations. The QUITY UPL H-lass io System retains all of these benefits while bringing increased compatibility for biomolecule analysis. With its flow-through-needle injector and quaternary solvent delivery system, the QUITY UPL H-lass io System has been specifically engineered with an inert flow path and uto lend Plus Technology to deliver the benefits of UPL in a system optimized for the analysis of proteins, peptides, nucleic acids, and glycans. The QUITY UPL H-lass io System delivers the same high quality separations that you expect from UPL, with the flexibility and ruggedness to run whatever mode of chromatography you require ion exchange (IEX), size exclusion (SE), hydrophilic interaction (HILI), or reversed phase all on the same system. You can perform the required specific assays for protein characterization including peptide mapping, intact protein analysis, and glycan analysis. QUITY UPL H-lass io System. HROMTOGRPHI FLEXIILIT Y Reversed phase Ion exchange (IEX) Size exclusion (SE) Hydrophilic interaction (HILI)

uto lend Plus Technology Efficient gradient management, systematic method development, and reliable routine operation One of Waters key technologies is uto lend Plus, a patented software technique that maximizes separation selectivity by using pure solvents and concentrated buffer stocks with the QUITY UPL H-lass io System s quaternary solvent manager. Desired mobile phase combinations and gradients are automatically blended on demand to match the optimum retention and selectivity requirements of the separation. INITIL ONDITIONS NaH 2 PO 4 0% 1000 mm Nal 25 mm Sodium Phosphate 0 mm Nal ph 6.8 ph 6.1 D Na 2 HPO 4 80% Water FINL ONDITIONS NaH 2 PO 4 50% 1000 mm Nal D Na 2 HPO 4 30% Water 25 mm Sodium Phosphate 500 mm Nal ph 6.8 uto lend Plus calculates the percentage of flow taken from each of the four solvents at each point in the gradient time range. The user programs the desired ph and ionic strength gradient to be derived from the stored library of buffers. In reversed phase separations, for example peptide maps or protein analysis, the method can be adjusted by changing the concentration of mobile phase modifier and the organic solvent. Instead of manually preparing many solvent mixtures, the QUITY UPL H-lass io System makes blends from pure solvents and concentrated stocks on demand. This process ensures that the optimum method is identified and that the method can then be transferred to other laboratories and run routinely with less chance of variability. uto lend Plus provides flexibility to use common protein separation techniques with the QUITY UPL H-lass io System. oth IEX and SE are optimized with the careful adjustment of ph and ionic strength, typically a labor-intensive and painstakingly iterative method development and adjustment process. With uto lend Plus, you can specify the ph and ionic strength required for the mobile phase and have the software calculate the proportions of buffer stocks required for the desired conditions. The automated computation can be based on known pk values or an empirical calibration table, making any possible buffer combination available. Users can also create their own library of unique buffer combinations. This proprietary software ensures the best separation conditions are identified and routinely used with the QUITY UPL H-lass io System maximizing laboratory productivity. 0.12 0.06 ph 6.9 ph 7.0 ph 7.1 ph 7.6 + 5.00 1 mixture of proteins alpha-hymotrypsinogen (peak ), Ribonuclease (peak ), and ytochrome (peak ) was separated using cation exchange chromatography using the QUITY UPL H-lass io System with a Protein-Pak Hi Res SP, 7 µm, 4.6 x 100 mm olumn. uto lend Plus Technology was used to automatically find the optimum concentration of mobile phase modifier in an unattended series of automated runs without the need to prepare several individual solvents. Note the small protein peak (peak ) that elutes in the center at ph 6.1, coelutes with the first peak at ph 7.0, and moves to elute as the first peak at ph 7.6.

enefits of uplc FoR IosePRtIons UPL delivers the sensitivity, resolution, and throughput required for biomolecule analyses, giving you the answers that you need more readily. Increased resolution and sensitivity Exceptional resolution is possible with UPL because separations obtained using sub-2-µm columns can only be achieved with instrumentation that provides reduced system volumes and minimized band broadening to preserve the high efficiency of these separations. This reduced system dispersion is combined with exact control of flow and compositional accuracy to ensure complete control over retention and selectivity. dditionally, Waters offers a series of QUITY UPL columns and chemistries specific for bioseparations. Each of these separation technologies is developed, proven, and quality-control tested with the intended application. This is the trademark of UPL Technology a holistic design philosophy that is founded on maximizing your chromatographic potential. 7.5e-2 7.0e-2 6.5e-2 6.0e-2 5.5e-2 5.0e-2 4.5e-2 4.0e-2 3.5e-2 3.0e-2 2.5e-2 2.0e-2 HPL UPL 7 72.00 74.00 76.00 78.00 8 82.00 84.00 omparing a section of a peptide map of Phosphorylase b from 68 to 85 min, the improvement in resolution from HPL to UPL is clearly observed. With UPL, more peaks are resolved and the peaks are sharper making it much easier to detect and quantitate the small peaks that represent trace amount of modified or damaged protein. Time Increased productivity UPL is more than just fast L. With fast L, separation parameters are modified to reduce the time of the separation, but compromises to resolution, sensitivity, or robustness are commonly required. UPL provides increased throughput that is made possible by better sensitivity and chromatographic resolution; this means less frequent need to reanalyze samples that have marginal or unexpected results. 1.60 1.20 0.80 0.40 8.9% This translates into measureable business benefits including lower cost of analysis, faster decisions, and reduced time-to-market giving you the competitive advantage. However, when fast is what s needed, measureable improvements in run time can be made by optimizing your separation using smaller particles, or decreasing your column length. 0.70 1.40 2.10 2.80 3.50 4.20 4.90 5.60 The QUITY UPL H-lass io System, and proprietary QUITY UPL EH200 SE 1.7-µm column chemistry, can be used to measure aggregates relative to the amount of monomeric IgG. This SE analysis of a humanized monoclonal antibody delivers improved resolution and sensitivity in under 3.7 min.

100 % 0 1900 2000 2100 2200 2300 2400 2500 2600 2700 2800 2900 3000 3100 3200 3300 3400 m/z 2.00 RP 1.00 7.00 14.00 21.00 0.030 IEX 0.015 0 2.00 4.00 6.00 0.18 SE uilt FoR RelIle opertion under demnding conditions Working together with our users scientists dedicated to strength aqueous conditions commonly used for protein supporting research and businesses focused on biopharmaceutical separations. dditionally, the system flow path has been tested products Waters developed the QUITY UPL H-lass io to ensure that it minimizes undesirable protein interactions and System specifically to make chromatography of biological leaching of material into the mobile phase. The result: a system macromolecules easier and more robust. onstructed with that is ideally suited for routine, trouble-free operation with materials that were selected as the ultimate in corrosion the maximum recovery of biomolecules without inadvertent resistance, the system is uniquely suited for the high ionic modification during analysis. using uto lend Plus with the cquity uplc h-class io system for multi-mode structural characterization of a chimeric monoclonal antibody Reversed phase L/MS used with the QUITY UPL H-lass io System to measure glycosylation variation, structural changes, and posttranslational modifications. ation exchange chromatography used with the QUITY UPL H-lass io System to measure charge variants. Size exclusion chromatography used with the QUITY UPL H-lass io System to measure aggregates and other variations in size and shape. 0.09 2.00 4.00 6.00

SYST EM H L LM RK S P PLITIONS FLEXIILIT Y Multi-solvent blending The QUITY UPL H-lass io System is suited for a variety of biochemical characterization applications. Here, the system is used for the analysis of glycans of human IgG using HILI and fluorescence detection. The QUITY UPL H-lass io System provides laboratories with the ultimate in flexibility with its multi-solvent blending capability, allowing for binary, ternary, or quaternary gradient operation. The addition of an optional, six-port solvent select valve greatly expands your solvent choices allowing you to optimize method conditions. sample introduction that s reliably quantitative The system s flow-through-needle sample manager is accurate and precise with excellent sample recovery and virtually no carryover, resulting in more reliable and reproducible results. detection optimized for uplc separations 2 UPL separation is not complete without innovative, ultra-low-dispersion detectors designed to maintain peak integrity. Waters offers the widest range of UPL-optimized detectors from optical to mass spectrometry enabling you to meet multiple detection requirements for biological applications. 5 9 6 3 ccurate column temperature control variety of column heaters and multi-column managers (with column switching) offers the lowest possible dispersion and exact temperature management for the best control of chromatographic selectivity and the highest retention time precision. ccurate results are ensured using methods that can be seamlessly transferred to other laboratories down the hall or around the world. 1 10.0 7 4 15.0 12 8 10 20.0 1 2 3 4 5 6 7 8 9 10 11 12 G0 G0F G0FGN G1 G1Fa G1Fb G1FGN G2 G2F G2FGN G1F+S G2F+S 11 25.0 30.0 Pooled human IgG was digested with PNGase F, and the released glycans were labeled with 2-aminobenzamide. The separation was performed using the QUITY UPL H-lass io System equipped with a fluorescence detector and an QUITY UPL EH Glycan, 1.7-µm, 2.1 x 150 mm olumn.

the comprehensive solution FoR IoPhRMceutIcl PPlIctIons cquity uplc h-class io system Quaternary Solvent Manager Sample Manager olumn heaters and multi-column managers uplc optimized detection capabilities Photodiode rray UV/Visible Fluorescence Evaporative Light Scattering Single and tandem quadrupole mass detectors Time-of-Flight mass spectrometers software and informatics Empower and MassLynx software iopharmalynx pplication Manager Full range of applications Peptide mapping Intact protein analysis Ion exchange Size exclusion Reversed phase Glycan analysis Oligonucleotide analysis E SSURED. HOOSE WTERS GLOL SERVIES. Waters Global Services focuses on optimizing Waters products with superior service, support, upgrades, training, and Waters Quality Parts. For more information, go to www.waters.com/services. Waters, QUITY UPL, and UPL are registered trademarks of Waters orporation. uto lend Plus, Empower, MassLynx, iopharmalynx, MassPREP, Protein-Pak, and The Science of What s Possible are trademarks of Waters orporation. ll other trademarks are the property of their respective owners. 2010 Waters orporation. Printed in the U.S.. June 2011 720003482EN O-P Waters orporation 34 Maple Street Milford, M 01757 U.S.. T: 1 508 478 2000 F: 1 508 872 1990 www.waters.com